The measles, mumps and rubella (MMR) vaccination was first introduced in the UK in 1988 [1]. Since then, cases of measles, mumps and rubella has steadily declined to very low rates [2]. Prior to its UK introduction, MMR has been in regular used in the US since 1972 and Scandinavia since 1982 [3] plus a number of European countries have adopted its usage. The wealth of experience that exists glo...

BACKGROUND Screening tests are available to determine immunity to vaccine-preventable diseases, such as mumps and rubella. We aimed to define better assay for detecting immune status of health care personnel to vaccine-preventable diseases. METHODS Mumps and rubella antibodies of health care personnel at Shimane University Hospital were examined by hemagglutination inhibition assay (HI), comp...

BACKGROUND Immunization is one of the most successful public health initiatives in Canada, yet continuous monitoring of coverage rates is essential to ensure high uptake for sustained success. The purpose of this study was to utilize newly available data from the Saskatchewan Immunization Management System (SIMS) to examine city and neighbourhood uptake of the Measles, Mumps and Rubella vaccine...

A survey of all general practitioners in Fife conducted prior to the introduction of measles-mumps-rubella immunization on a pilot basis in May 1987 showed that 85% considered mumps worth preventing and 94% believed the rubella programme worth augmenting with universal childhood immunization. Ninety seven per cent considered measles worth preventing and 98% were prepared to recommend measles-mu...

BACKGROUND In the Netherlands, epidemics of vaccine preventable diseases are largely confined to an orthodox protestant minority with religious objections to vaccination. The clustering of unvaccinated children in orthodox protestant schools can foster the spread of epidemics. School closure has nevertheless not been practiced up until now. A mumps epidemic in 2007-2008 gave us an opportunity t...

BACKGROUND In Iran, the measles, mumps and rubella vaccine (MMR) is administered in a two-dose protocol where the first dose is scheduled at 12 months of age. This study aims to determine the efficacy of the MMR vaccine by testing IgM and IgG antibody levels 4 - 7 weeks after primary vaccination. METHODS A single group cohort study was performed on healthy children, 12 - 15 months of age, who...

From 1 January to 14 April 2011, a total of 155 measles cases were notified in Belgium, whereas throughout 2010, there were only 40. Of the 103 cases with known vaccination status, 87% had not been vaccinated with measles-mumps-rubella vaccine. The resurgence of measles is the consequence of insufficient vaccine coverage in previous years. Efforts to communicate the benefits of measles vaccinat...

1. In general, HIV-1 infected individuals should not receive any live viral or bacterial vaccines (eg. Measles/Mumps/Rubella, monovalent Rubella, BCG, yellow fever, oral Typhoid Ty21a, varicella-zoster, oral Polio, vaccinia). There have been instances of lethal infections with live vaccinia vaccines following vaccination of HIV-infected persons.(3) This principle however applies particularly to...

Vaccines have saved millions of lives and reduced the severity many infections, but today reduction in vaccine coverage has been reflected resurgence epidemics mumps, whooping cough, measles chickenpox. This happened because people do not recognize effectiveness vaccination fear side effects, other words, main concern is safety vaccines. As a consequence, greater responsibility individual respe...

BACKGROUND AND OBJECTIVE During 2009-2010, a northeastern US religious community experienced a large mumps outbreak despite high 2-dose measles-mumps-rubella (MMR) vaccine coverage. A third dose of MMR vaccine was offered to students in an affected community in an effort to control the outbreak. METHODS Eligible sixth- to 12th-grade students in 3 schools were offered a third dose of MMR vacci...